Brief introduction of 57709-61-2

As the paragraph descriping shows that 57709-61-2 is playing an increasingly important role.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.57709-61-2,1,10-Phenanthroline-2,9-dicarboxylic acid,as a common compound, the synthetic route is as follows.

57709-61-2, Dark red crystals of 2 were prepared in a similar way to 1 except forusing H2O/MeCN (10 mL, v/v=1/1) instead of MeOH. Product wasisolated in 73percent yield based on Fe. Anal. Calcd. for C32H22FeN7O8: C55.83, H 3.22, N 14.24percent Found C 54.13, H 2.88, N 12.93percent. IR (selectedbands): 3067 (m), 1638 (s), 1508 (w), 1365 (s), 1271 (s), 875(m), 812 (s), 709 (m) cm?1.

As the paragraph descriping shows that 57709-61-2 is playing an increasingly important role.

Reference£º
Article; Ramezanpour, Behnaz; Mirzaei, Masoud; Jodaian, Vida; Niknam Shahrak, Mahdi; Frontera, Antonio; Molins, Elies; Inorganica Chimica Acta; vol. 484; (2019); p. 264 – 275;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

Analyzing the synthesis route of 57709-61-2

As the paragraph descriping shows that 57709-61-2 is playing an increasingly important role.

57709-61-2, 1,10-Phenanthroline-2,9-dicarboxylic acid is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Under anhydrous conditions, 4-dimethylaminopyridine (DMAP,340 mg, 2.8 mmol, 2.5 equiv), N-(3-dimethylaminopropyl)-N?-ethylcarbodiimide hydrochloride (EDC¡¤HCl, 640 mg, 3.4 mmol,3.0 equiv), and 3-aminoquinoline (450 mg, 3.1 mmol, 2.8 equiv)were added as solids to a suspension of compound 3 (3.0¡¤102mg, 1.1 mmol, 1.0 equiv) in DMF (23 mL). The solution wasplaced under argon and stirred at room temperature (48 h). Theresulting yellow suspension was filtered under vacuum, and theisolated precipitate washed with saturated aqueous sodiumbicarbonate (30 mL), CH2Cl2 (20 mL), and diethyl ether (20 mL)to afford pure compound 4 as a pale yellow solid (490 mg, 85percent).1H NMR (300 MHz, DMSO-d6): delta = 7.68 (t, 3J = 7 Hz, 2 H), 7.75 (t,3J = 7 Hz, 2 H), 8.09?8.13 (m, 4 H), 8.33 (s, 2 H), 8.69 (d, 3J = 8 Hz,2 H), 8.91 (d, 3J = 8 Hz, 2 H), 9.17 (d, 4J = 2 Hz, 2 H), 9.68 (d, 4J = 2Hz, 2 H), 11.88 (s, 2 H); mp >280 ¡ãC (lit. >260 ¡ãC).7, 57709-61-2

As the paragraph descriping shows that 57709-61-2 is playing an increasingly important role.

Reference£º
Article; Miron, Caitlin E.; Petitjean, Anne; Synlett; vol. 29; 10; (2018); p. 1362 – 1366;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI